Driving culture change in the pursuit of oncology value
Five years ago, if you asked oncologists at my practice to name the list price of a given chemotherapy agent, most wouldn’t have known–unless they were executives, maybe. Pharmaceutical reps rarely talk about costs. The EMRs don’t give list prices. And when we input drug orders back then, no cost analyses were offered.
These days, those same oncologists can quote efficacy and cost data chapter and verse for a variety of …